You have 9 free searches left this month | for more free features.

Condition

COVID-19 Infection (1)

Coronary Artery Disease (1)

Diabetes Mellitus, Type 2 (1)

Kidney Failure, Chronic (1)

Pulmonary Arterial Hypertension (1)

Overall Status

Completed (2)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Resverlogix Corp (3)

Steeve Provencher (1)

Collaborator

ICON plc (1)

Medidata Solutions (1)

PPD (1)

Resverlogix Corp (1)

Intervention

apabetalone (4)

atorvastatin (1)

placebo (1)

placebos (1)

rosuvastatin (1)

standard of care (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

apabetalone

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

COVID-19 Infection Trial in Edmonton (Apabetalone, Standard of care)

Recruiting

COVID-19 Infection

Apabetalone
Standard of care

Edmonton, Alberta, Canada

University of Alberta

Jan 19, 2022

Pulmonary Arterial Hypertension Trial in Calgary, Quebec City (Apabetalone)

Completed

Pulmonary Arterial Hypertension

Apabetalone

Calgary, Alberta, Canada
+1 more

Apr 22, 2022

Kidney Failure, Chronic Trial (apabetalone, Placebos)

Unknown status

Kidney Failure, Chronic

apabetalone
Placebos

(no location specified)

Jul 11, 2019

Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

Completed

Diabetes Mellitus, Type 2
Coronary Artery Disease

Apabetalone
+3 more

Bahía Blanca, Argentina
+213 more

Jul 23, 2021